Denmark-based biology company Octarine began producing psilocybin via a brewer’s yeast called Saccharomyces cerevisiae. While producing less than previous strains of bacteria and yeast this has proven to be the cheapest method. While losing about half of the production to psilocin conversion they are trying to work through those issues. They believe that the yeast processes are too similar to our stomach digestion and converting the psilocybin to psilocin. While still useful and may have a higher binding rate to Serotonin receptors, they are trying to make more psilocybin as that’s what they are testing. The reason for all of this is to make psilocybin more available to scientists and healthcare researchers. Traditionally, Psilocybin mushrooms are grown from spores, but this process is costly and labor-intensive under good practice methods. This is a step for companies to be able to collect more data and run more tests at a cheaper rate.
Related Articles
Carlos Castaneda: Anthropologist, Mystic, and Visionary.
Carlos Castaneda is one of the most notable figures in the late 60’s New Age countercultural movement. He began his career as a young anthropologist studying shamanic traditions with Peyote, Datura, and magic mushrooms, and died as a controversial figure. He’s...
Groundbreaking New Research on the Origins of Psilocybin
Tracing the Genealogy of Psilocybin Close your eyes and imagine an Earth before humans, before borders, before time itself. Before Doordash and doomscroll, before innocence and guilt, there was only this: the Precambrian soup from which all organic life emerged. Cells...
Unearthing The Terence McKenna Archive
Bring up Terence McKenna to the average psychedelic mushroom enthusiast and you’re bound to hear any number of the following things: tales of personal encounters with the elusive machine-elves; an vaguely tasteless impression of his vaguely extraterrestrial voice; a...